EUVIMEDEUVIMED entdecken
Crossref

Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy

Min Hong iD, Xiaoyan Liu, Qinghong Ji, Mengyao Ou, Qiaoli Yue, Shuang Cheng

Drug Delivery and Translational Research · 2025-08 · 15 (8) · 2848-2861

DOI: 10.1007/s13346-024-01783-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 03.01.2025. Verfasst von Min Hong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng, 252059, China. hongmin@lcu.edu.cn. Hauptthemen laut MEDLINE: Folic Acid, Antineoplastic Agents, Piperazines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erastin, as an effective ferroptosis inducer, has received extensive attention in anti-tumor research. To develop an oral nanocarrier for high efficient loading hydrophobic erastin, here we prepared a fluoro-liposome (FA-3 F-LS) by the self-assembly of the folic acid modified fluorinated amphiphiles-FA-3 F conjugates. The hydrophobic component of three perfluorooctyl chains endows the FA-3 F-LSs with high stability to resist the harsh gastrointestinal tract condition. Folic acids conjugated on the surface of FA-3 F-LSs ensure the better tumor targeting and higher oral bioavailability (32.1%) of erastin-loaded FA-3 F-LSs (erastin@FA-3 F-LSs) than free erastin (8.98%). As targeted anti-tumor nanomedicines, erastin@FA-3 F-LSs effectively inhibited the tumor cell proliferation in vitro by inducing ferroptosis through enhancing the glutathione (GSH) depletion, lipid peroxidation and generation of reactive oxygen species. In vivo studies demonstrated that FA-3 F-LSs displayed excellent application potential as a tumor-targeted oral drug delivery nanocarrier to depress the tumor growth with the loaded chemotherapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidAntineoplastic AgentsPiperazinesAnimalsLiposomesHumansAdministration, OralFerroptosisCell Line, TumorMiceMice, Inbred BALB CCell ProliferationGlutathioneMice, NudeBiological AvailabilityReactive Oxygen SpeciesDrug Delivery Systems

Stichwörter der Autor:innen

ErastinFerroptosisFluorinated amphiphileFluoro-liposomeOral deliveryTargeted anti-tumor therapy

Substanzen

Folic AcidLiposomesAntineoplastic AgentserastinPiperazinesGlutathioneReactive Oxygen Species

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng, 252059, China. hongmin@lcu.edu.cn.
  • School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng, 252059, China.
  • School of Agricultural Science and Engineering, Liaocheng University, Liaocheng, 252059, China.

ORCID-Profile: Min Hong

Förderung

  • Shandong Provincial Natural Science Foundations

Zitieren

APA

Hong, M., Liu, X., Ji, Q., Ou, M., Yue, Q., & Cheng, S. (2025). Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy. Drug Delivery and Translational Research, 15(8), 2848-2861. https://doi.org/10.1007/s13346-024-01783-8

Vancouver

Hong M, Liu X, Ji Q, Ou M, Yue Q, Cheng S. Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy. Drug Delivery and Translational Research. 2025;15(8):2848-2861. doi:10.1007/s13346-024-01783-8

BibTeX
@article{Hong2025,
  author = {Hong, Min and Liu, Xiaoyan and Ji, Qinghong and Ou, Mengyao and Yue, Qiaoli and Cheng, Shuang},
  title = {Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  volume = {15},
  number = {8},
  pages = {2848--2861},
  doi = {10.1007/s13346-024-01783-8}
}
Kostenlos starten →